Aspergillus species are the most frequent cause of invasive mold infections
in immunocompromised patients, Although over 180 species are found within
the genus, 3 species, Aspergillus flavus, A. fumigatus, and A. terreus, acc
ount for most cases of invasive aspergillosis (ZA), with A. nidulans, A. ni
ger, and A. ustus being rare causes of IA. The ability to distinguish betwe
en the various clinically relevant Aspergillus species may have diagnostic
value, as certain species are associated with higher mortality and increase
d virulence and vary in their resistance to antifungal therapy, A method to
identify Aspergillus at the species level and differentiate it from other
true pathogenic and opportunistic molds was developed using the 18S and 28S
rRNA genes for primer binding sites. The contiguous internal transcribed s
pacer (ITS) region, ITS 1-5.8S-ITS 2, from referenced strains and clinical
isolates of aspergilli and other fungi were amplified, sequenced, and compa
red with non-reference strain sequences in GenBank. ITS amplicons from Aspe
rgillus species ranged in size from 565 to 613 bp. Comparison of reference
strains and GenBank sequences demonstrated that both ITS I and ITS 2 region
s were needed for accurate identification of Aspergillus at the species lev
el. Intraspecies variation among clinical isolates and reference strains wa
s minimal. Sixteen other pathogenic molds demonstrated less than 89% simila
rity with Aspergillus ITS 1 and 2 sequences, A blind study of 11 clinical i
solates was performed, and each was correctly identified. Clinical applicat
ion of this approach may allow for earlier diagnosis and selection of effec
tive antifungal agents for patients with IA.